The guidelines for asthma care in adolescents and adults have been changed, but what about children?Children aged six to 11 years are still being prescribed the blue puffer as first-line therapy, while older people are prescribed a combination inhaler with a corticosteroid.Now a major New Zealand study published in the Lancet suggests children should also be swapped over to a combined inhaler to reduce asthma attacks.Guest/sDr Paul Robinson, Professor of Respiratory and Sleep Medicine at Queensland Children’s Hospital and a Research Leader at the Woolcock Research InstituteReferencesBudesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related